Automatic hemostatic suture-free stent blood vessel and use method thereof
Through the automatic hemostatic stent, the blood vessels use the elasticity of blood pressure and nickel-titanium alloy to close the anastomosis of the chest aorta, the problem of long-term vascular anastomosis in the existing technology is solved, and the rapid and effective hemostatic effect is achieved, reducing nerves Systemic complication risk.
Patent Information
- Application Number
- CN202110098128.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-01-25
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2041-01-25
AI Technical Summary
The existing surgical treatment methods for thoracic aortic lesions require autologous blood vessels to be cut off and replaced with artificial blood vessels under extracorporeal circulation, resulting in high vascular anastomosis technology requirements and a long suture process, increasing the risk of neurological complications in patients.
The automatic hemostatic and suture-free stent blood vessels are used to utilize the elasticity of human blood pressure or nickel-titanium alloy to clamp the autologous vascular anastomosis port in an expanded state through the lever assembly and the coated stent to achieve suture-free hemostatic hemostatic.
It effectively reduces the surgical time, reduces the extracorporeal circulation time, reduces the possibility of neurological complications in patients, and has good hemostasis effect.
Smart Images

Figure CN112773558B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to an automatic hemostatic suture-free stent blood vessel and a use method thereof. Background Art
[0002] Currently, surgical treatment for thoracic aortic disease is generally to perform artificial blood vessel (1) replacement and stent implantation under extracorporeal circulation. Because this method cuts off the autologous blood vessels and replaces them with artificial blood vessels (1), it requires very high vascular anastomosis technology. At the same time, because the internal hemostasis requirements are high, the suturing process is extremely time-consuming. The longer the extracorporeal circulation time, the greater the possibility of patients suffering from neurological complications.
[0003] Therefore, how to minimize the extracorporeal circulation time is one of the main goals of thoracic aortic surgery. Summary of the invention
[0004] According to the above-mentioned existing surgical treatment methods for thoracic aortic lesions, the autologous blood vessels are cut off and replaced with artificial blood vessels, so the requirements for vascular anastomosis technology are very high. At the same time, due to the high requirements for internal hemostasis, the suturing process is extremely time-consuming. The longer the time under extracorporeal circulation, the greater the possibility of patients suffering from neurological complications. In order to solve the technical problem, an automatic hemostatic suture-free stent blood vessel and a method of using the same are provided. The present invention mainly utilizes the elasticity of human blood pressure or nickel-titanium alloy to clamp the anastomosis of the autologous blood vessel and the artificial blood vessel with a lever preset on the outside of the artificial blood vessel, thereby achieving the purpose of suture-free hemostasis.
[0005] The technical means adopted by the present invention are as follows:
[0006] An automatic hemostatic suture-free stent blood vessel acts on an autologous blood vessel, comprising: a plurality of lever assemblies, an artificial blood vessel and a covered stent with expansion and compression functions, the distal end of the artificial blood vessel being integrally connected with the proximal end of the covered stent, the covered stent being placed in the autologous blood vessel to support the autologous blood vessel in an expanded state; a plurality of fulcrums of the lever assemblies being arranged outside the artificial blood vessel or the covered stent, being circumferentially uniformly arranged, the lever assemblies rotating around the fulcrums, the power end of the lever assemblies being connected to the distal end of the artificial blood vessel;
[0007] The power for driving the lever assembly to rotate comes from the blood pressure inside the artificial blood vessel, wherein the artificial blood vessel is filled with blood when working, and the internal blood pressure will make the artificial blood vessel reach its maximum outer diameter. The power end is lifted up by utilizing the lever principle, driving the lever assembly to rotate toward the inside of the native blood vessel to press on the outer wall of the native blood vessel, and at the same time, press the native blood vessel on the built-in coated stent in an expanded state, so that the coated stent is tightly connected to the native blood vessel, and suture-free hemostasis is achieved by clamping and closing the anastomosis.
[0008] Furthermore, the distal end of the artificial blood vessel is turned over to the inside of the stent graft, and as the stent graft is compressed, the fulcrum and the power end are turned over inside the stent graft at the same time;
[0009] The lever assembly is driven to rotate by pulling the artificial blood vessel, wherein the proximal end of the artificial blood vessel is pulled to pull out the portion of the artificial blood vessel that is flipped up inside the coated stent, and at the same time the power end is pulled out of the coated stent, driving the lever assembly to rotate at a larger angle, so that the coated stent is tightly connected to the autologous blood vessel, and then the internal blood pressure of the artificial blood vessel is used to increase the compression force between the coated stent and the autologous blood vessel, thereby achieving suture-free hemostasis.
[0010] Furthermore, a power support is provided near the distal end of the artificial blood vessel, the power end is connected to the power support, a metal support ring is sleeved on the outside of the power support, and the expansion and compression of the power support are achieved by the expansion and contraction of the metal support ring; the power support is connected to the artificial blood vessel as a whole, and the artificial blood vessel can move with the movement of the power support;
[0011] The power for driving the lever assembly to rotate comes from the combined effect of the pre-compressed metal stent ring preset on the artificial blood vessel and blood pressure, wherein after removing the external restraint of the metal stent ring, the metal stent ring restores the preset outer diameter, lifts the power end, and drives the lever assembly to rotate, so that the coated stent is tightly connected to the autologous blood vessel, and then the internal blood pressure of the artificial blood vessel is used to increase the compression force between the coated stent and the autologous blood vessel, thereby achieving suture-free hemostasis.
[0012] Furthermore, the metal stent ring is a corrugated ring or a mesh ring.
[0013] Furthermore, the power end is located outside the power support, and the connection between the two is a soft connection, a mechanical rotation connection or a hard connection.
[0014] Furthermore, a fulcrum fixing ring is provided on the distal outer wall of the artificial blood vessel, and the two have a good fit; the fulcrum is connected to the fulcrum fixing ring and is evenly distributed on the outer circumference of the fulcrum fixing ring;
[0015] The size of the fulcrum fixing ring is fixed and does not change with the size of the power stent or the artificial blood vessel.
[0016] Furthermore, the number of the lever assemblies is 6-18.
[0017] Further, the lever assembly is composed of a power end, a resistance end and a fulcrum, the resistance end is placed outside the stent graft, the fulcrum is arranged at the connection between the resistance end and the power end, the power end is fixedly connected to the human blood vessel, and is lifted or pressed as the human blood vessel expands or compresses, and the resistance end and the power end are driven to rotate circumferentially around the fulcrum at the same time by utilizing the lever principle;
[0018] When the power end is lifted up, the rotated resistance end is placed outside the proximal end of the autologous blood vessel, and at the same time, the resistance end presses the outer wall of the autologous blood vessel into the autologous blood vessel, pressing it against the built-in coated stent in the expanded state, thereby achieving suture-free hemostasis.
[0019] Furthermore, the power end and the resistance end have different lengths.
[0020] Furthermore, the power end and the resistance end have curvatures that conform to human vascular anatomy.
[0021] Furthermore, the resistance end is in the shape of a spindle, an ellipse, a strip or a rod.
[0022] Furthermore, a layer of covering film for protecting the blood vessels is covered between the resistance end and the autologous blood vessels.
[0023] Furthermore, the coated stent comprises 1 stent main branch and 0-1 stent branches.
[0024] Furthermore, the coated stent is composed of a coating that serves to block blood (hemostasis function) and a stent frame that serves to support the stent; the stent frame is a corrugated stent body woven from metal wires, and the coating is a tubular film attached to the inside or outside of the stent frame, wherein the stent frame is arranged inside or outside the coating, and the two are integrated by suturing or bonding, and the proximal end of the coating is integrally connected to the distal end of the artificial blood vessel; the stent frame is made of superelastic metal wire, and thus the coated stent can be compressed to a smaller diameter in advance and restrained to achieve the purpose of reducing its diameter, so as to facilitate entry into the blood vessel lumen, and the expansion and compression of the coated stent can be achieved by removing the restraint outside the coated stent.
[0025] Furthermore, the stent frame is made of nickel-titanium alloy.
[0026] Furthermore, the artificial blood vessel comprises 1 main branch and 0-4 branches.
[0027] Furthermore, the artificial blood vessel is made of polyester or polytetrafluoroethylene.
[0028] The present invention also provides a method for using an automatic hemostatic suture-free stent blood vessel, comprising the following steps:
[0029] The distal end of the artificial blood vessel is flipped to the proximal end of the stent graft, and as the stent graft is compressed, the power end of the lever assembly is also flipped inside the stent graft, and the resistance end of the lever assembly is located outside the artificial blood vessel;
[0030] When the stent graft is placed inside a human blood vessel, the restraints outside the stent graft are removed, and the stent graft now supports the native blood vessel;
[0031] Then, the proximal end of the artificial blood vessel inside the stent graft is pulled toward the operator's proximal end, and the part of the artificial blood vessel inside the stent graft is flipped and pulled out. At this time, the power end is located outside the artificial blood vessel close to its distal end, and the resistance end is flipped and rotated to the outside of the native blood vessel;
[0032] The interior of the artificial blood vessel is then filled with blood, which props up the artificial blood vessel, and the artificial blood vessel lifts up the power end. Under the action of the lever principle, the resistance end has a compression force given by the blood pressure to the inside of the blood vessel, which stops the blood at the anastomosis and achieves the purpose of suture-free hemostasis.
[0033] The present invention also provides a method for using an automatic hemostatic suture-free stent blood vessel, comprising the following steps:
[0034] During aortic arch replacement surgery, the middle section of the patient's aortic arch needs to be removed;
[0035] Place the compressed covered stent into the inner lumen of the descending aorta until the aortic stump fits the distal end of the pivot fixing ring;
[0036] The restraints outside the stent graft are removed, and the stent graft expands and returns to its original diameter, propping up the aortic wall from the inside;
[0037] The external restraint of the powered stent is removed, and the powered stent expands and drives the connected artificial blood vessel to expand as well;
[0038] At this time, the power end of the lever assembly is driven by the expansion of the power support, causing the lever assembly to rotate around its fulcrum, and the resistance end of the lever assembly is pressed against the outer wall of the aorta under the action of the lever principle;
[0039] The proximal end of the artificial blood vessel is clamped to open the blood flow path of the descending aorta. The artificial blood vessel is further filled under the action of blood pressure, and its size is restored to the preset state. The power end receives the pressure of blood pressure, which increases the force of the resistance end to press the outer wall of the artery, and the artery is tightly pressed against the coated stent to prevent blood from flowing out, thereby achieving the effect of suture-free hemostasis.
[0040] Compared with the prior art, the present invention has the following advantages:
[0041] The automatic hemostatic suture-free stent blood vessel comprises an artificial blood vessel, a coated stent, a lever assembly, etc. The distal end of the artificial blood vessel is connected to the proximal end of the coated stent; the lever assembly comprises a power end, a resistance end and a fulcrum; a fixed ring may be provided on the outer wall of the artificial blood vessel; the fulcrum of the lever assembly is connected to the fixed ring, so that the lever can change the position of the power end and the resistance end relative to the artificial blood vessel around the fulcrum. The automatic hemostatic suture-free stent blood vessel of the present invention utilizes blood pressure and / or the elasticity of the power stent to clamp and close the anastomosis, thereby eliminating the method of suturing the anastomosis in artificial blood vessel replacement surgery, thereby achieving the effect of hemostasis and reducing the operation time.
[0042] 1. The automatic hemostatic suture-free stent blood vessel and its use method provided by the present invention use the lever principle, metal stent ring and / or blood pressure as the hemostatic power, and press the outer surface of the blood vessel to close the anastomosis and stop bleeding. This hemostatic method is intermittent compression hemostasis. Compared with externally tightening the outer wall of the blood vessel with a lock or silk thread to stop bleeding, the hemostatic method of the present invention can make the outer wall of the blood vessel evenly compressed, and the hemostatic effect is good.
[0043] 2. The automatic hemostatic suture-free stent blood vessel and the use method thereof provided by the present invention are quick to operate and can effectively reduce the operation time.
[0044] In summary, the technical solution of the present invention can solve the problem that the existing surgical treatment methods for thoracic aortic lesions cut off the autologous blood vessels and replace them with artificial blood vessels, so the vascular anastomosis technology is very high, and because the internal hemostasis requirements are high, the suturing process is very time-consuming. The longer the extracorporeal circulation time, the greater the possibility of patients suffering from neurological complications.
[0045] Based on the above reasons, the present invention can be widely promoted in the fields of medical devices and the like. BRIEF DESCRIPTION OF THE DRAWINGS
[0046] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.
[0047] Figure 1 This is a schematic diagram of the structure of the automatic hemostatic suture-free stent blood vessel according to Example 1 of the present invention.
[0048] Figure 2 It is a side view of the automatic hemostatic suture-free stent blood vessel according to Example 1 of the present invention.
[0049] Figure 3 This is a diagram of the state before use of the automatic hemostatic suture-free stent blood vessel of Example 1 of the present invention.
[0050] Figure 4 This is a schematic diagram of the process of implanting a covered stent into an autologous blood vessel in the automatic hemostatic suture-free stent blood vessel according to Example 1 of the present invention.
[0051] Figure 5 This is a schematic diagram of the automatic hemostatic suture-free stent blood vessel of Example 1 of the present invention after use, in which the covered stent is placed in the autologous blood vessel without expansion.
[0052] Figure 6 This is a schematic diagram of the close pressing of the autologous blood vessel and the covered stent after the use of the automatic hemostatic suture-free stent blood vessel according to Example 1 of the present invention.
[0053] Figure 7 This is a schematic diagram of the structure of the automatic hemostatic suture-free stent blood vessel according to Example 4 of the present invention.
[0054] Figure 8 This is a diagram of the state before use of the automatic hemostatic suture-free stent blood vessel of Example 4 of the present invention.
[0055] Fig. 9 It is a rear view of the automatic hemostatic suture-free stent blood vessel according to Example 4 of the present invention.
[0056] In the figure: 1. artificial blood vessel; 2. covered stent; 21. stent frame; 22. covered membrane; 3. lever assembly; 31. power end; 32. resistance end; 33. fulcrum; 34. fulcrum fixing ring; 4. power stent. DETAILED DESCRIPTION
[0057] It should be noted that, in the absence of conflict, the embodiments of the present invention and the features in the embodiments can be combined with each other. The present invention will be described in detail below with reference to the accompanying drawings and in combination with the embodiments.
[0058] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. The following description of at least one exemplary embodiment is actually only illustrative and is by no means intended to limit the present invention and its application or use. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0059] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0060] Unless otherwise specifically stated, the relative arrangement of the parts and steps described in these embodiments, the numerical expressions and numerical values do not limit the scope of the present invention. At the same time, it should be clear that, for ease of description, the sizes of the various parts shown in the drawings are not drawn according to the actual proportional relationship. The technology, methods and equipment known to ordinary technicians in the relevant field may not be discussed in detail, but in appropriate cases, the technology, methods and equipment should be regarded as part of the authorization specification. In all examples shown and discussed here, any specific value should be interpreted as merely exemplary, rather than as a limitation. Therefore, other examples of exemplary embodiments may have different values. It should be noted that similar numbers and letters represent similar items in the following drawings, so once an item is defined in one drawing, it does not need to be further discussed in subsequent drawings.
[0061] As shown in the figure, the present invention provides an automatic hemostatic suture-free stent blood vessel, which acts on an autologous blood vessel, comprising: a plurality of lever assemblies 3 and an artificial blood vessel 1 and a coated stent 2 with expansion and compression functions, wherein the distal end of the artificial blood vessel 1 is integrally connected with the proximal end of the coated stent 2, and the coated stent 2 is inserted into the autologous blood vessel to support the autologous blood vessel in an expanded state; a plurality of fulcrums 33 of the lever assemblies 3 are arranged on the outside of the artificial blood vessel 1 or the coated stent 2, and are uniformly arranged in the circumferential direction, and the lever assemblies 3 rotate around the fulcrums 33, and the power end 31 of the lever assembly 3 is connected to the distal end of the artificial blood vessel 1.
[0062] The power for driving the lever assembly 3 to rotate comes from the blood pressure inside the artificial blood vessel 1, wherein, when the artificial blood vessel 1 is working, it is filled with blood flow, and its internal blood pressure will make the artificial blood vessel 1 reach its maximum outer diameter. The power end 31 is lifted up by utilizing the lever principle, driving the lever assembly 3 to rotate toward the inside of the native blood vessel and press on the outer wall of the native blood vessel, while pressing the native blood vessel onto the built-in coated stent 2 in an expanded state, so that the coated stent 2 is pressed and connected with the native blood vessel, and suture-free hemostasis is achieved by clamping and closing the anastomosis.
[0063] Preferably, the distal end of the artificial blood vessel 1 is flipped to the inside of the stent graft 2, and as the stent graft 2 is compressed, the fulcrum 33 and the power end 31 are flipped to the inside of the stent graft 2 at the same time;
[0064] The lever assembly 3 is driven to rotate by pulling the artificial blood vessel 1, wherein the proximal end of the artificial blood vessel 1 is pulled to pull out the part of the artificial blood vessel 1 that is flipped over inside the coated stent 2, and at the same time, the power end 31 is pulled out of the coated stent 2 to drive the lever assembly 3 to rotate at a larger angle, so that the coated stent 2 is tightly connected with the autologous blood vessel, and then the internal blood pressure of the artificial blood vessel 1 is used to increase the compression force between the coated stent 2 and the autologous blood vessel, thereby achieving suture-free hemostasis.
[0065] Preferably, a power support 4 is provided near the distal end of the artificial blood vessel 1, the power end 31 is connected to the power support 4, a metal support ring is sleeved on the outside of the power support 4, and the expansion and compression of the power support 4 are achieved by the expansion and contraction of the metal support ring; the power support 4 is connected to the artificial blood vessel 1 as a whole, and the artificial blood vessel 1 can move with the movement of the power support 4;
[0066] The power for driving the lever assembly 3 to rotate comes from the combined effect of the pre-compressed metal stent ring preset on the artificial blood vessel 1 and blood pressure, wherein after removing the external restraint of the metal stent ring, the metal stent ring restores the preset outer diameter, lifts the power end 31, and drives the lever assembly 3 to rotate, so that the coated stent 2 is tightly connected with the autologous blood vessel, and then the internal blood pressure of the artificial blood vessel 1 is used to increase the compression force between the coated stent 2 and the autologous blood vessel, thereby achieving suture-free hemostasis.
[0067] Preferably, the metal stent ring is a corrugated ring or a mesh ring.
[0068] Preferably, the power end 31 is located outside the power bracket 4, and the connection between the two is a soft connection, a mechanical rotation connection or a hard connection.
[0069] Preferably, the distal outer wall of the artificial blood vessel 1 is provided with a fulcrum fixing ring 34, and the two have a good fit; the fulcrum 33 is connected to the fulcrum fixing ring 34 and is evenly distributed on the outer edge circumference of the fulcrum fixing ring 34;
[0070] The size of the fulcrum fixing ring 34 is fixed and does not change with the size of the power support 4 or the artificial blood vessel 1 .
[0071] Preferably, the number of the lever assemblies 3 is 6-18.
[0072] Preferably, the lever assembly 3 is composed of a power end 31, a resistance end 32 and a fulcrum 33, wherein the resistance end 32 is disposed outside the stent graft 2, and the fulcrum 33 is disposed at the connection between the resistance end 32 and the power end 31, and the power end 31 is fixedly connected to the human blood vessel, and is lifted or pressed as the human blood vessel expands or compresses, and the resistance end 32 and the power end 31 are driven to rotate circumferentially around the fulcrum 33 simultaneously by utilizing the lever principle;
[0073] When the power end 31 is lifted up, the rotated resistance end 32 is placed outside the proximal end of the autologous blood vessel. At the same time, the resistance end 32 presses the outer wall of the autologous blood vessel toward the inside of the autologous blood vessel, pressing it against the built-in coated stent 2 in an expanded state, thereby achieving suture-free hemostasis.
[0074] Preferably, the power end 31 and the resistance end 32 have different lengths.
[0075] Preferably, the power end 31 and the resistance end 32 have curvatures that conform to human vascular anatomy.
[0076] Preferably, the resistance end 32 is in the shape of a spindle, an ellipse, a strip or a rod.
[0077] Preferably, a layer of covering film for protecting the blood vessels is covered between the resistance end 32 and the autologous blood vessels.
[0078] Preferably, the coated stent 2 comprises 1 stent main branch and 0-1 stent branches.
[0079] Preferably, the coated stent 2 is composed of a coating 22 for blocking blood (hemostasis function) and a stent frame 21 for supporting function; the stent frame 21 is a corrugated stent body woven from metal wires, and the coating 22 is a layer of tubular membrane attached to the inside or outside of the stent frame 21, wherein the stent frame 21 is arranged inside or outside the coating 22, and the two are integrated by suturing or bonding, and the proximal end of the coating 22 is integrally connected with the distal end of the artificial blood vessel 1; the stent frame 21 is made of superelastic metal wire, and accordingly, the coated stent 2 can be compressed to a smaller diameter in advance and restrained to achieve the purpose of reducing its diameter, so as to facilitate entry into the blood vessel lumen, and the expansion and compression of the coated stent 2 can be achieved by removing the restraint outside the coated stent 2.
[0080] Preferably, the stent frame 21 is made of nickel-titanium alloy.
[0081] Preferably, the artificial blood vessel 1 comprises 1 main branch and 0-4 branches.
[0082] Preferably, the artificial blood vessel 1 is made of polyester or polytetrafluoroethylene.
[0083] Example 1
[0084] like Figure 1-6 As shown, an automatic hemostatic suture-free stent blood vessel includes an artificial blood vessel 1 with an inner layer made of polyester, a coated stent 2 and 12 groups of lever components 3.
[0085] The distal end of the artificial blood vessel 1 is connected to the proximal end of the stent graft 2 .
[0086] The coated stent 2 includes a stent skeleton 21 and a coating 22 made of nickel-titanium alloy. In this embodiment, the artificial blood vessel 1 and the coated stent 2 are both straight cylindrical and have no branches. The coated stent 2 is composed of a coating 22 that blocks blood (hemostasis function) and a stent skeleton 21 that supports; the stent skeleton 21 is a corrugated stent body woven from metal wires, and the coating 22 is a layer of tubular film attached to the inside or outside of the stent skeleton 21, wherein the stent skeleton 21 is arranged inside or outside the coating 22, and the two are sutured or bonded together, and the proximal end of the coating 22 is integrally connected with the distal end of the artificial blood vessel 1; the stent skeleton 21 is made of superelastic metal wire, and the coated stent 2 can be compressed to a smaller diameter in advance and bound to achieve the purpose of reducing its diameter, so as to facilitate entry into the lumen of the blood vessel, and the expansion and compression of the coated stent 2 can be achieved by removing the restraint outside the coated stent 2.
[0087] The lever assembly 3 includes a power end 31 made of nickel-titanium alloy, an elliptical resistance end 32 and a fulcrum 33. The power end 31 and the resistance end 32 have curvatures that conform to the anatomy of human blood vessels and are of different lengths. A protective film is provided between the resistance end 32 and the autologous blood vessel.
[0088] The fulcrum 33 is connected to the outside of the artificial blood vessel 1 , and the connection is close to the coated stent 2 .
[0089] Example 2
[0090] The first method for using the automatic hemostatic suture-free stent blood vessel described in Example 1 comprises the following steps:
[0091] The artificial blood vessel 1 does not flip over, and the power that drives the lever assembly 3 to rotate comes from the blood pressure inside the artificial blood vessel 1: the artificial blood vessel 1 is filled with blood, and the filled blood props up the artificial blood vessel 1, and the artificial blood vessel 1 lifts the power end 31 of the lever assembly 3. Under the action of the lever principle, the resistance end 32 has a force toward the inside of the blood vessel given by the blood pressure, which stops the blood at the anastomosis and achieves the purpose of no suture.
[0092] Example 3
[0093] A second method for using the automatic hemostatic suture-free stent blood vessel described in Example 1 comprises the following steps:
[0094] The distal end of the artificial blood vessel 1 is turned over to the proximal end of the coated stent 2 and is compressed along with the coated stent 2. At this time, the fulcrum 33 of the lever assembly 3 is also turned over inside the coated stent 2. At this time, the power end 31 of the lever assembly 3 is also turned over inside the coated stent 2, and the resistance end 32 is located outside the artificial blood vessel 1.
[0095] When the stent graft 2 is placed inside a human blood vessel, the restraints outside the stent graft 2 are removed, and the stent graft 2 now supports the native blood vessel;
[0096] Then, the proximal end of the artificial blood vessel 1 located inside the stent graft 2 is pulled toward the proximal end of the operator, and the part of the artificial blood vessel 1 flipped inside the stent graft 2 is pulled out. At this time, the power end 31 of the lever assembly 3 is located outside the artificial blood vessel 1 near the distal end, and the resistance end 32 is flipped to the outside of the native blood vessel 1;
[0097] At this time, the interior of the artificial blood vessel 1 is filled with blood, and the filled blood props up the artificial blood vessel 1, which lifts the power end 31 of the lever assembly 3. Under the action of the lever principle, the resistance end 32 has a force toward the inside of the blood vessel given by the blood pressure, which stops the blood at the anastomosis and achieves the purpose of avoiding suturing.
[0098] Example 4
[0099] Different from Example 1, in this embodiment, the stent graft 2 comprises 1 stent main branch and 0-1 stent branches, and the stent main branch is Figure 1The stent graft structure shown in the figure has a stent branch which is another stent structure with a small diameter extending out from the side opening of the stent main branch. The artificial blood vessel 1 comprises 1 main branch and 0-4 branches. The main branch is Figure 1 The artificial blood vessel structure shown has a branch that is another artificial blood vessel structure with a small diameter extending out from the side opening of the main branch.
[0100] Example 5
[0101] like Figure 7-9 As shown, different from Example 1, in this embodiment, an automatic hemostatic suture-free stent blood vessel comprises an artificial blood vessel 1 made of polytetrafluoroethylene, a coated stent 2, 18 sets of lever assemblies 3, a fulcrum fixing ring 34 arranged on the outer wall of the distal end of the artificial blood vessel 1, and a power stent 4. The power stent 4 is arranged at a position near the distal end of the artificial blood vessel 1, and a metal stent ring is sleeved on its outer surface. The expansion and compression of the power stent 4 are achieved by the telescopic movement of the metal stent ring, and the metal stent ring is an elastic wave-shaped ring.
[0102] The distal end of the artificial blood vessel 1 is connected to the proximal end of the coated stent 2 .
[0103] The fulcrum fixing ring 34 is connected to the artificial blood vessel 1, and the two have a good fit.
[0104] The fulcrum 33 of the lever assembly 3 is connected to the fulcrum fixing ring 34 and is evenly distributed on the outer circumference of the fulcrum fixing ring 34 .
[0105] The power end 31 and the strip resistance end 32 of the lever assembly 3 can rotate around the fulcrum 33, and the rotation action is located on a plane perpendicular to the fulcrum fixing ring 34 and where the fulcrum 33 is located. Specifically, the fulcrum 33 is connected to the fulcrum fixing ring 34, so that the lever assembly can change the position of the power end 31 and the resistance end 32 relative to the artificial blood vessel 1 around the fulcrum 33.
[0106] The size of the fulcrum fixing ring 34 is fixed and does not change with the size of the stent or artificial blood vessel 1 .
[0107] The power end 31 is located outside the power support 4, and the two can be connected in a certain way, and the connection method can be a soft connection, a mechanical rotation connection or a hard connection.
[0108] The power support 4 is connected to the artificial blood vessel 1 as a whole, and the artificial blood vessel 1 can move along with the movement of the power support 4 .
[0109] Example 6
[0110] The method for using the automatic hemostatic suture-free stent blood vessel described in Example 5 comprises the following steps:
[0111] During aortic arch replacement surgery, the middle section of the patient's aortic arch needs to be removed;
[0112] like Fig. 9 As shown, the compressed stent graft 2 is placed into the inner cavity of the descending aorta until the stump of the aorta is attached to the distal end of the fulcrum fixing ring 34;
[0113] The restraint outside the stent graft 2 is removed, and the stent graft 2 expands and returns to its original diameter, propping up the aortic wall from the inside;
[0114] The external restraint of the power stent 4 is removed, and the power stent 4 expands and drives the artificial blood vessel 1 connected thereto to expand as well;
[0115] At this time, the power end 31 of the lever assembly 3 is driven to expand by the power support 4, the lever assembly 3 rotates around its fulcrum 33, and the resistance end 32 of the lever assembly 3 is pressed against the outer wall of the aorta under the action of the lever principle;
[0116] The proximal end of the artificial blood vessel 1 is clamped to open the blood flow path of the descending aorta. The artificial blood vessel 1 is further filled under the action of blood pressure and its size is restored to a preset state. The power end 31 of the lever assembly 3 receives the pressure of blood pressure, which increases the force of the resistance end 32 pressing the outer wall of the artery, and the artery is tightly pressed onto the coated stent 2 to prevent blood from flowing out, thereby achieving the effect of suture-free hemostasis.
[0117] The present invention utilizes the elasticity of blood pressure and / or the power support 4 to clamp and seal the anastomosis, thereby eliminating the need for suturing the anastomosis during artificial blood vessel 1 replacement surgery, thereby achieving the effects of hemostasis and reducing the operation time.
[0118] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. An automatic hemostatic suture-free stent blood vessel, acting on an autologous blood vessel, characterized in that: include: A plurality of lever assemblies (3) and an artificial blood vessel (1) and a coated stent (2) having expansion and compression functions, wherein the distal end of the artificial blood vessel (1) is integrally connected to the proximal end of the coated stent (2), and the coated stent (2) is placed in an autologous blood vessel to support the autologous blood vessel in an expanded state; the lever assembly (3) is composed of a power end (31), a resistance end (32) and a fulcrum (33), and the fulcrums (33) of the plurality of lever assemblies (3) are arranged outside the artificial blood vessel (1) or the coated stent (2) and are evenly arranged in the circumferential direction; the lever assembly (3) rotates around the fulcrum (33), and the power end (31) of the lever assembly (3) is connected to the distal end of the artificial blood vessel (1); The power for driving the lever assembly (3) to rotate comes from the blood pressure inside the artificial blood vessel (1), wherein when the artificial blood vessel (1) is working, it is filled with blood flow, and the internal blood pressure causes the artificial blood vessel (1) to reach its maximum outer diameter. The power end (31) is lifted up by the lever principle, and the lever assembly (3) is driven to rotate toward the inside of the autologous blood vessel to press on the outer wall of the autologous blood vessel, and at the same time, the autologous blood vessel is pressed on the built-in coated stent (2) in an expanded state, so that the coated stent (2) is pressed and connected with the autologous blood vessel, and suture-free hemostasis is achieved by clamping and closing the anastomosis. The distal end of the artificial blood vessel (1) is flipped into the interior of the coated stent (2), and as the coated stent (2) is compressed, the fulcrum (33) and the power end (31) are simultaneously flipped into the interior of the coated stent (2); The lever assembly (3) is driven to rotate by pulling the artificial blood vessel (1), wherein the proximal end of the artificial blood vessel (1) is pulled to pull out the portion of the artificial blood vessel (1) that is flipped over inside the coated stent (2), and at the same time the power end (31) is pulled out of the coated stent (2), driving the lever assembly (3) to rotate, so that the coated stent (2) is tightly connected to the autologous blood vessel, and then the internal blood pressure of the artificial blood vessel (1) is used to increase the compression force between the coated stent (2) and the autologous blood vessel, thereby achieving suture-free hemostasis.
2. The automatic hemostatic suture-free stent blood vessel according to claim 1, characterized in that: A power support (4) is provided near the distal end of the artificial blood vessel (1); the power end (31) is connected to the power support (4); a metal support ring is sleeved on the outside of the power support (4); the expansion and compression of the power support (4) are achieved through the expansion and contraction of the metal support ring; the power support (4) is connected to the artificial blood vessel (1) as a whole; the artificial blood vessel (1) can move along with the movement of the power support (4); The power for driving the lever assembly (3) to rotate comes from the combined effect of the pre-compressed metal stent ring preset on the artificial blood vessel (1) and the blood pressure, wherein after the external restraint of the metal stent ring is removed, the metal stent ring restores the preset outer diameter, lifts the power end (31), and drives the lever assembly (3) to rotate, so that the coated stent (2) is pressed and connected with the autologous blood vessel, and then the internal blood pressure of the artificial blood vessel (1) increases the pressing force between the coated stent (2) and the autologous blood vessel, thereby achieving suture-free hemostasis.
3. The automatic hemostatic suture-free stent blood vessel according to claim 2, characterized in that: The metal support ring is a wave-shaped ring or a mesh ring.
4. The automatic hemostatic suture-free stent blood vessel according to claim 2, characterized in that: The power end (31) is located outside the power bracket (4), and the connection between the two is a flexible connection, a mechanical rotation connection or a hard connection.
5. The automatic hemostatic suture-free stent blood vessel according to claim 2, characterized in that: The distal outer wall of the artificial blood vessel (1) is provided with a fulcrum fixing ring (34), and the two have a good fit; the fulcrum (33) is connected to the fulcrum fixing ring (34) and is evenly distributed on the outer circumference of the fulcrum fixing ring (34); The size of the fulcrum fixing ring (34) is fixed and does not change with the size of the power support (4) or the artificial blood vessel (1).
6. The automatic hemostatic suture-free stent blood vessel according to claim 1, characterized in that: The number of the lever assemblies (3) is 6-18.
7. The automatic hemostatic suture-free stent blood vessel according to claim 1, 2 or 6, characterized in that: The resistance end (32) is placed outside the coated stent (2), and the fulcrum (33) is arranged at the connection between the resistance end (32) and the power end (31). The power end (31) is fixedly connected to the artificial blood vessel (1) and is lifted or pressed as the artificial blood vessel (1) expands or compresses. The resistance end (32) and the power end (31) are driven to rotate circumferentially around the fulcrum (33) simultaneously by utilizing the principle of a lever; When the power end (31) is lifted up, the resistance end (32) is placed outside the proximal end of the autologous blood vessel after rotation. At the same time, the resistance end (32) presses the outer wall of the autologous blood vessel into the autologous blood vessel, pressing it onto the built-in coated stent (2) in an expanded state, thereby achieving suture-free hemostasis.
8. The automatic hemostatic suture-free stent blood vessel according to claim 7, characterized in that: The power end (31) and the resistance end (32) have different lengths; The power end (31) and the resistance end (32) have curvatures that conform to the anatomy of human blood vessels.
9. The automatic hemostatic suture-free stent blood vessel according to claim 7, characterized in that: The resistance end (32) is in the shape of a spindle, an ellipse, a strip or a rod.
10. The automatic hemostatic suture-free stent blood vessel according to claim 7, characterized in that: A layer of covering film for protecting the blood vessel is covered between the resistance end (32) and the autologous blood vessel.
11. The automatic hemostatic suture-free stent blood vessel according to claim 1 or 2, characterized in that: The coated stent (2) is composed of a coating (22) for blocking blood and a stent frame (21) for supporting the stent; the stent frame (21) is a corrugated stent body woven from metal wires, and the coating (22) is a layer of tubular film attached to the inside or outside of the stent frame (21), wherein the stent frame (21) is arranged inside or outside the coating (22), and the two are integrated by suturing or bonding, and the proximal end of the coating (22) is integrally connected to the distal end of the artificial blood vessel (1); the stent frame (21) is made of metal wire with superelasticity, thereby the coated stent (2) can be compressed and restrained in advance to achieve the purpose of reducing its diameter, so as to facilitate its entry into the blood vessel lumen, and the coated stent (2) can be expanded by removing the restraint outside the coated stent (2); The support frame (21) is made of nickel-titanium alloy.
12. The automatic hemostatic suture-free stent blood vessel according to claim 1 or 2, characterized in that: The artificial blood vessel (1) is made of polyester or polytetrafluoroethylene; The artificial blood vessel (1) comprises 1 main branch and 0-4 branches; The coated stent (2) comprises 1 stent main branch and 0-1 stent branches.
